CollPlant Biotechnologies (CLGN) Assets Average (2019 - 2025)

CollPlant Biotechnologies' Assets Average history spans 7 years, with the latest figure at $14.7 million for Q4 2025.

  • For Q4 2025, Assets Average fell 44.18% year-over-year to $14.7 million; the TTM value through Dec 2025 reached $14.7 million, down 44.18%, while the annual FY2025 figure was $14.7 million, 44.18% down from the prior year.
  • Assets Average reached $14.7 million in Q4 2025 per CLGN's latest filing, down from $26.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $44.5 million in Q4 2022 to a low of $14.7 million in Q4 2025.
  • Average Assets Average over 5 years is $30.5 million, with a median of $31.0 million recorded in 2021.
  • Peak YoY movement for Assets Average: skyrocketed 187.43% in 2021, then crashed 44.18% in 2025.
  • A 5-year view of Assets Average shows it stood at $31.0 million in 2021, then skyrocketed by 43.39% to $44.5 million in 2022, then fell by 19.21% to $35.9 million in 2023, then dropped by 26.51% to $26.4 million in 2024, then plummeted by 44.18% to $14.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Assets Average are $14.7 million (Q4 2025), $26.4 million (Q4 2024), and $35.9 million (Q4 2023).